X

Neurostar TMS Therapy

A Ground Breaking New Depression Therapy Treatment

Dr. Kristina Harrington and Dr. Olurotimi Ashaye are excited to announce the addition of NeuroStar TMS Therapy to the 2017 MidValley Healthcare program.

What is TMS Depression Therapy?

TMS (Transcranial Magnetic Stimulation) uses a targeted pulse magnetic field, similar to what is used in an MRI (Magnetic Resonance Imaging) machine. While the patient is awake and alert, Neurostar TMS Therapy stimulates areas of the brain that are underactive in depression.

Indication for Major Depression Disorder

NeuroStar TMS Therapy is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode.

NeuroStar TMS Therapy is only available by prescription. A doctor can help decide if NeuroStar TMS Therapy is right for you.


How TMS Depression Therapy Works


TMS Depression Treatment Expectations


Insurance Coverage for Treatment

 

Want to learn more about TMS?

 
Learn More

A Major Burdern for Society Today:

Looking at the entire world, we see that major depression is an enormous burden on society. In fact, in 2004 the World Health Organization rated unipolar major depression as the third most significant cause of disability worldwide…

*The World Health Organization. The World Health Report 2004: Changing History, Annex Table 3: Burden of disease in DALYs by cause. Geneva: WHO, 2004.

Current Drug Treatment Paradigm for Depression

depression therapy boise meridian

There are a variety of first-line treatment options for major depression, which typically begins with the use of SSRIs. When these agents fail, treatment is typically to switch to a different antidepressant class, such as an MAOI or TCA. When these agents fail to provide benefit, the next treatment step is to move on to various augmentation strategies (such as adding Lithium or thyroid hormone) and, ultimately, to augmentation with an atypical antipsychotic . Clinicians may use a somewhat different treatment order, but in general, physicians begin this cascade of treatment attempts with a relatively simple antidepressant approach to obtain efficacy with minimal side effects. It is only when initial treatment fails, that physicians must move on to the more complex and, unfortunately, more toxic, drugs. This approach has certainly been shown to get many people well, and psychiatry has done a remarkable job employing these antidepressant agents.

STAR*D Study demonstrates that current treatment has limited effectiveness

You may have experienced this lack of available, effective treatments for patients who have failed to benefit from initial antidepressant treatment. Let’s take a closer look at the evidence of the STAR*D study because it tells the same story. The design of this study involved four treatment Levels. These Levels were pre-specified by expert consensus, and were intended to reflect the general approach taken in clinical practice at the time STAR*D was constructed, which was about 10 years ago.

tms depression therapy boise
tms depression treatment boise meridian

Likelihood of discontinuing treatment increases with each new medication attempt

What the STAR*D study also shows, as shown here, is that while study discontinuation rates due to side effects is relatively low initially (about 9%), it rises very rapidly - nearly tripling in the transition from Level 1 (about 9%) to Level 2 (about 23%). Therefore, by the time patients had failed to benefit from three prior antidepressant treatments, nearly half of the patients discontinued further treatment due to adverse events.

Ready to Make an Appointment?

Intensive Outpatient Treatment bridges the needs between traditional outpatient and acute psychiatric hospitalization.

Contact Today

Have you or a loved one benefited from one of our programs?

Share Here